Farnesylamine from the Ant Monomorium fieldi Forel
| dc.contributor.author | Jones, T. | |
| dc.contributor.author | Clark, D. | |
| dc.contributor.author | Heterick, Brian E. | |
| dc.contributor.author | Snelling, R. | |
| dc.date.accessioned | 2017-01-30T12:11:17Z | |
| dc.date.available | 2017-01-30T12:11:17Z | |
| dc.date.created | 2013-10-11T06:04:19Z | |
| dc.date.issued | 2003 | |
| dc.identifier.citation | Jones, T.H. and Clark, D.A. and Heterick, B.E. and Snelling, R.R. 2003. Farnesylamine from the Ant Monomorium fieldi Forel. Journal of Natural Products. 66 (3): pp. 325-326. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/19007 | |
| dc.identifier.doi | 10.1021/np020558f | |
| dc.description.abstract |
(2E)- and (2Z)-Farnesylamine were detected in the extracts of the myrmicine ant Monomorium fieldi Forel from Australia. Their structures were established by direct comparison with synthetic (2E)- and (2Z)-farnesylamine. This finding of a sesquiterpene is unique in a genus known to produce unbranched fatty acid derived alkaloids and amines. Additionally, while farnesylamine has not been reported from natural sources, the synthetic material has been shown to have a variety of biological activities. | |
| dc.publisher | American Chemical Society and American Society of Pharmacognosy | |
| dc.title | Farnesylamine from the Ant Monomorium fieldi Forel | |
| dc.type | Journal Article | |
| dcterms.source.volume | 66 | |
| dcterms.source.number | 3 | |
| dcterms.source.startPage | 325 | |
| dcterms.source.endPage | 326 | |
| dcterms.source.issn | 01633864 | |
| dcterms.source.title | Journal of Natural Products | |
| curtin.department | ||
| curtin.accessStatus | Fulltext not available |